BNY Mellon has created a range of indices for investors who want to utilize Depositary Receipts (DRs) in their portfolios. The BNY Mellon DR indices track DRs that trade on the NYSE, NYSE American, NASDAQ and LSE, as well as over the counter (OTC) in the United States. BNY Mellon indices span specific markets, regions, countries and investment strategies, and are all calculated on a continuous basis throughout the relevant markets’ trading days. There are six BNY Mellon index families based on trading venue: the BNY Mellon ADR Index℠ (U.S. exchange-listed DRs); the BNY Mellon GDR Index℠ (LSE exchange-listed DRs); the BNY Mellon DR Index℠ (U.S. and LSE exchange-listed DRs); the BNY Mellon Classic ADR Index℠ (U.S. exchange-listed and OTC DRs); the OTCM ADR Index (U.S. OTC DRs); and the BNY Mellon Composite Depositary Receipt Index℠ (U.S. and LSE exchange-listed and U.S. OTC DRs).
All information for an index prior to its Launch Date is hypothetical back-tested, not actual performance, based on the index methodology in effect on the Launch Date. Back-tested performance reflects application of an index methodology and selection of index constituents with the benefit of hindsight and knowledge of factors that may have positively affected its performance, cannot account for all financial risk that may affect results and may be considered to reflect survivor/look ahead bias. Actual returns may differ significantly from, and be lower than, back-tested returns. Past performance is not an indication or guarantee of future results. This back-tested data may have been created using a “Backward Data Assumption”. For more information on “Backward Data Assumption” and back-testing in general, please see the Performance Disclosure.